The Americas
Europe
Europe
Asia-Pacific
Middle East & Africa
Key Dates
Monitor
Research
Explore
Analyze
Explore
Manufacturing topics
Quality topics
Life Science Technologies
Pharmaceuticals
Medical Devices
Digital Health
Advanced Therapies
Diagnostics
Industry Technology
Software & platforms powering regulatory, quality, clinical and manufacturing teams
Quality
Regulatory
Clinical & Safety
Manufacturing
Industry Spotlight
Submit a MilestoneExplore
Specialties
Specialties
Home/Companies/Edwards Lifesciences
Company
Irvine, California structural-heart company tracing to 1958, whose Starr-Edwards valve was the first commercially successful artificial heart valve; it acquired Autus Valve Technologies in February 2026 to bring AUTUS to market.
1 story
Regulatory News has published 1 story about Edwards Lifesciences on 2 October 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 2 October 2026.
This page is generated from Regulatory News’ editorial coverage of Edwards Lifesciences. It is not an advertisement.
Our coverage
